CNBC's Paulina Likos and Zev Fima discuss which Investing Club stocks could come out on top as investors scrutinize AI ...

With 2026 a bit more than half over, Berkshire Hathaway's B shares are down 1.8% year-to-date and 12.4 percentage points ...

Interest in brain-computer interfaces is rising as it promises to help people with compromised neural abilities.

The two companies entered into a high-profile partnership in 2024 when ChatGPT was integrated into the iPhone's operating ...

The largest housing bill in decades has just become law after weeks of tense political standoff between President Trump and ...

People are self-optimizing everything — protein, skincare, fitness — to such a degree that "maxxing" is one of social media's ...

CNBC’s MacKenzie Sigalos reports on Apple’s claims that OpenAI employees and recruits took confidential documents, physical ...

"Funflation," the rising cost of concerts, sporting events and travel, is surging across America. But alternatives at home, ...

CNBC's Pippa Stevens reports on how disrupted traffic through the Strait of Hormuz and Ukraine increasing attacks on Russian ...

CNBC's Paulina Likos and Zev Fima discuss Wall Street's shift from AI euphoria toward rationalization and what it means for investors.

Vivani Medical is developing an implant of semaglutide, the active ingredient in Novo Nordisk's obesity injection Wegovy and ...

Ferrari shares are up 17% since falling after unveiling its panned Luce model. Two banks still see more potential in the stock.